Invasive adenocarcinoma with bronchoalveolar features: A population-based evaluation of the extent of resection in bronchoalveolar cell carcinoma Bryan A. Whitson, MD, PhD, Shawn S. Groth, MD, MS, Rafael S. Andrade, MD, Mohi O. Mitiek, MD, Michael A. Maddaus, MD, Jonathan D’Cunha, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 143, Issue 3, Pages 591-600.e1 (March 2012) DOI: 10.1016/j.jtcvs.2011.10.088 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Sample inclusion and exclusion selection criteria. BAC, Bronchoalveolar cell carcinoma; SEER, Surveillance, Epidemiology, and End Results. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 591-600.e1DOI: (10.1016/j.jtcvs.2011.10.088) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 (A) Overall survival and (B) cancer-specific survival for patients with bronchoalveolar cell carcinoma histologic features who underwent either lobar or sublobar resection. (C) Overall survival and (D) cancer-specific survival for those patients who underwent anatomic resection (lobectomy or segmentectomy) and nonanatomic resection (wedge resection). Survival denoted on y-axis, with time in months along x-axis. Below the graph, number at risk for each is indicated. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 591-600.e1DOI: (10.1016/j.jtcvs.2011.10.088) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions